EPC · XBRL financial data
EDGEWELL PERSONAL CARE Company financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (EPC's year ends in late September)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 534 | 489 | 599 | 648 | 518* | 478 | 581 | 627 | 537* | 423 | 520 | 570 |
| Cost of goods and services sold | 304* | 291 | 341 | 361 | 305* | 287 | 325 | 359 | 329* | 262 | 303 | 328 |
| Gross profit | 229 | 198 | 258 | 287 | 213* | 192 | 256 | 269 | 209* | 161 | 217 | 243 |
| Research and development | 16* | 13 | 14 | 15 | 16* | 14 | 14 | 14 | 16* | 14 | 15 | 13 |
| Selling, general and administrative | 112* | 103 | 108 | 110 | 109* | 103 | 106 | 104 | 112* | 102 | 111 | 108 |
| Operating income (loss) | 54* | 26 | 70 | 83 | 20* | 20 | 59 | 54 | (36)* | (19) | 18 | 25 |
| Interest expense | 19* | 20 | 20 | 19 | 18* | 19 | 20 | 19 | 15* | 19 | 18 | 17 |
| Income tax expense (benefit) | 4* | 1 | 11 | 14 | (3)* | 0 | 12 | 8 | (23)* | (8) | 4 | 6 |
| Net income (loss) | 30 | 5 | 36 | 49 | 9* | (2) | 29 | 29 | (31)* | (66) | (11) | 14 |
| Earnings per share, basic USD per share | 0.59 | 0.10 | 0.72 | 0.99 | 0.18* | (0.04) | 0.60 | 0.62 | (0.66)* | (1.41) | (0.23) | 0.30 |
| Earnings per share, diluted USD per share | 0.58 | 0.09 | 0.72 | 0.98 | 0.18* | (0.04) | 0.60 | 0.62 | (0.66)* | (1.41) | (0.22) | 0.29 |
| Weighted average shares, basic millions of shares | 51* | 50 | 50 | 50 | 49* | 49 | 48 | 47 | 47* | 47 | 47 | 46 |
| Weighted average shares, diluted millions of shares | 52* | 51 | 50 | 50 | 50* | 49 | 48 | 47 | 47* | 47 | 47 | 47 |
Balance sheet
CSVFiscal quarters (EPC's year ends in late September)
Cash flows
CSVFiscal quarters (EPC's year ends in late September)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 30 | 5 | 36 | 49 | 9* | (2) | 29 | 29 | (31)* | (66) | (11) | 14 |
| Stock-based compensation | 8* | 7 | 6* | 7* | 6* | 6 | 6* | 6* | 6* | 3 | 6* | 6* |
| Depreciation and amortization | 23* | 23 | 22* | 22* | 21* | 22 | 22* | 22* | 23* | 21 | 19* | 19* |
| Net cash from operating activities | 48* | (73) | 129* | 101* | 74* | (116) | 45* | 115* | 74* | (126) | 54* | 119* |
| Net cash from investing activities | (19)* | (6) | (14)* | (17)* | (26)* | (16) | (17)* | (12)* | (28)* | (10) | 325* | (14)* |
| Share repurchases | 30* | 15 | 15* | 10* | 18* | 30 | 35* | 25* | 0* | 0 | 16* | 0* |
| Dividends paid | 8* | 8 | 8* | 8* | 7* | 8 | 7* | 7* | 7* | 7 | 7* | 7* |
| Net cash from financing activities | (14)* | 70 | (129)* | (80)* | (40)* | 110 | (37)* | (83)* | (19)* | 133 | (301)* | (7)* |
| Net change in cash | 9* | (2) | (18)* | (0)* | 13* | (34) | (5)* | 30* | 26* | (2) | 76* | 97* |
Compare with peers
SIC 2844 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Edgewell Personal Care | 397 | 570 | 119* | 46.1M | 10-QJun 30, 2026 |
| Stepan | 114 | 684 | 8.4* | 22.7M | 10-QJun 30, 2026 |
| Coty | 176 | 1,269* | 116* | 880.7M | 10-KJun 30, 2026 |
| Interparfums | not reported | 341 | 46* | 32.0M | 10-QJun 30, 2026 |
| e.l.f. Beauty | 344 | 479 | 112 | 59.0M | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.